Tarsus (NASDAQ:TARS) is a biopharmaceutical company that applies proven science and new technology to revolutionize treatment for patients, starting with eye care.
View Top Employees from Tarsus Pharmaceuticals, Inc.Website | http://www.tarsusrx.com |
Revenue | $4 million |
Funding | $60 million |
Employees | 253 (173 on RocketReach) |
Founded | 2017 |
Address | 15440 Laguna Canyon Rd, Irvine, California 92618, US |
Phone | (949) 409-9820 |
Technologies |
JavaScript,
HTML,
PHP
+40 more
(view full list)
|
Industry | Pharmaceuticals, Pharmaceutical Manufacturing, Healthcare |
Keywords | Biopharmaceuticals, Ophthalmic Care |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular Tarsus Pharmaceuticals, Inc. employee's phone or email?
The Tarsus Pharmaceuticals, Inc. annual revenue was $4 million in 2024.
Sesha Neervannan is the COO of Tarsus Pharmaceuticals, Inc..
173 people are employed at Tarsus Pharmaceuticals, Inc..
Tarsus Pharmaceuticals, Inc. is based in Irvine, California.
The NAICS codes for Tarsus Pharmaceuticals, Inc. are [32, 325, 32541, 3254].
The SIC codes for Tarsus Pharmaceuticals, Inc. are [28, 283].